Trial site
The Second Affiliated Hospital of Henan University of Science and Technology
- 9running trials
- 9closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Psoriasis7 trials
- Atopic dermatitis (eczema)3 trials
- Stroke3 trials
- Chronic spontaneous urticaria1 trial
- Migraine1 trial
- Neurofibromatosis type 11 trial
- Vitiligo1 trial
- Phase
- Phase 310 trials
- Phase 24 trials
- Phase 2/32 trials
- Status
- Completed8 trials
- Not yet recruiting5 trials
- Recruiting4 trials
- Terminated1 trial
- Lead sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.5 trials
- Beijing Tiantan Hospital3 trials
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2 trials
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.2 trials
- Akeso1 trial
- and 5 more
Running trials
Recruiting
A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis
Not yet recruiting
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
Recruiting
Recruiting
Recruiting
Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria
Recruiting
Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage
Recruiting
Recruiting
ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke2 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Chronic spontaneous urticaria1 recruiting
- Migraine1 recruiting
- Neurofibromatosis type 11 recruiting
- Psoriasis1 recruiting
- Vitiligo1 recruiting
Closed trials
Terminated
Completed
Recruiting
Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
Completed
Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study
Completed
Completed
Completed
Completed
Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026